Purpose Recent studies suggest that atrial fibrillation (AF) is associated with increased
cardiovascular risk and mortality including sudden cardiac death (SCD). According to the …

The management of cardiac arrhythmias has grown more complex in recent years. Despite
the recent focus on nonpharmacological therapy, most clinical arrhythmias are treated with …

Background—This double-blind, multicenter, placebo-controlled study determined the
efficacy and safety of dofetilide in converting atrial fibrillation (AF) or atrial flutter (AFl) to …

Atrial Fibrillation and Appropriate ICD Therapy. Introduction: Atrial fibrillation (AF) is
associated with significant morbidity and mortality that may be related to heniodynamic …

Objective: To conduct a meta-analysis of randomised controlled trials to estimate the
effectiveness of antiarrhythmic drugs at promoting sinus rhythm in patients with atrial …

Objectives: This study aimed to assess the prevalence of different types of atrial fibrillation
(AF) and their prognostic importance in implantable cardioverter-defibrillator (ICD) patients …

Atrial fibrillation (AF) is the most common clinically encountered abnormal heart beat. It is
associated with an increased risk of stroke and symptoms of heart failure. Current therapies …

When considering therapy for atrial fibrillation (AF), the dominant issues are rate control,
anticoagulation, rhythm control, and treatment of any underlying disorder. Drug choices for …

Adverse drug reactions (ADRs) occur frequently in modern medical practice, resulting in
increased morbidity and mortality and a higher cost of care. Patients with cardiovascular …

The clinical relevance and high social costs of atrial fibrillation have boosted interest in rate
control as a cost-effective alternative to long-term maintenance of sinus rhythm (ie rhythm …